Researchers at Columbia University College of Dental Medicine have developed an exosome-based platform, “safeEXO-Cas,” that significantly enhances the delivery of CRISPR/Cas9 genome editing components to specific cells and tissues.
Scientists develop new CRISPR gene editing platform for precision medicine and cancer treatment
Posted in bioengineering, biotech/medical